Weekly updateCompaniesRecruiting servicePost a job
Aeglea BioTherapeutics

Aeglea BioTherapeutics

    Company info:

  • 101-250
  • 2013
  • Austin, TX
  • 50-100M


aeglea.com

linkedin.com


Claim company profile

About company:

Aeglea BioTherapeutics is using human enzyme therapeutics to treat patients with rare metabolic diseases. Metabolism describes the network of life sustaining chemical reactions needed for health. Rare metabolic diseases typically result from a missing or defective enzyme which is needed to convert chemicals and therefore causes aberrant activity within a cell. Aeglea is using protein engineering to create enzyme-based therapeutics that are engineered to target the primary driver of metabolic diseases. Enzyme engineering involves either developing enzymes that possess advanced properties of existing enzymes or generating enzymes with novel activity. Aeglea is initially focusing on three diseases with ineffective treatment options: Homocystinuria, Arginase 1 Deficiency and Cystinuria.

Jobs:

Claim company profile to post jobs directly on this page and this website.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com